Current techniques for the diagnosis of prostate cancer, such as PSA measurement and digital rectal examination, are not supported by enough evidence to conclude either one alone achieves an unequivocal identification of malignancy in the prostate gland. The gene discussed is KLK3; the disease is prostate cancer.